Año: 2021
Journal Impact Factor (JIF): 5.9380
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| PHARMACOLOGY & PHARMACY | SCIE | 51/279 | Q1 | T1 | D2 |
| MICROBIOLOGY | SCIE | 35/137 | Q2 | T1 | D3 |
Año: 2021
Journal Citation Indicator (JCI): 1,320
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| MICROBIOLOGY | 25/158 | Q1 | T1 | D2 | 84,49 |
| PHARMACOLOGY & PHARMACY | 37/361 | Q1 | T1 | D2 | 89,89 |
Año:
2021
CiteScore:
9,300
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Pharmacology (medical) | 18/255 | Q1 | T1 | D1 |
| Infectious Diseases | 37/295 | Q1 | T1 | D2 |
| Pharmacology | 39/303 | Q1 | T1 | D2 |
SJR año:
2021
Factor de Impacto:
1,546
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Pharmacology | 24/327 | Q1 | T1 | D1 |
| Pharmacology (medical) | 16/283 | Q1 | T1 | D1 |
| Infectious Diseases | 47/333 | Q1 | T1 | D2 |
| Agencia | Código de Proyecto |
|---|---|
| Eli Lilly and Company Limited | - |
| German Federal Ministry of Education and Research | - |
| German Federal Ministry of Health, Medecins Sans Frontieres | - |
| Global Antibiotic Research and Development Partnership (GARDP) | - |
| Netherlands Ministry of Health, Welfare, and Sport | - |
| North West England Medical Research Council Fellowship Scheme in Clinical Pharmacology and Therapeutics - Medical Research Council | MR/N025989/1 |
| Novartis | - |
| Roche Pharma | - |
| U.K. Department for International Development | - |
| U.K. National Institute of Health Research | - |
| UCB Pharma | - |
| University of Liverpool | - |
| University of Manchester | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | University of Liverpool (United Kingdom) | |
| 2 | Docobo-Pérez, Fernando | Universidad de Sevilla (Spain) |
| 3 | Farrington, Nicola | University of Liverpool (United Kingdom) |
| 4 | Johnson, Adam | University of Liverpool (United Kingdom) |
| 5 | McEntee, Laura | University of Liverpool (United Kingdom) |
| 6 | Unsworth, Jennifer | University of Liverpool (United Kingdom) |
| 7 | Jimenez-Valverde, Ana | University of Liverpool (United Kingdom) |
| 8 | Gastine, Silke | UCL Great Ormond Street Institute of Child Health (United Kingdom) |
| 9 | Kolamunnage-Dona, Ruwanthi | University of Liverpool (United Kingdom) |
| 10 | de Costa, Renata M.A. | Global Antibiotic Research and Development Partnership (Switzerland) |
| 11 | Ellis, Sally | Global Antibiotic Research and Development Partnership (Switzerland) |
| 12 | Franceschi, François | Global Antibiotic Research and Development Partnership (Switzerland) |
| 13 | Standing, Joseph F. | UCL Great Ormond Street Institute of Child Health (United Kingdom) |
| 14 | Sharland, Mike | St George's University of London (United Kingdom) |
| 15 | Neely, Michael | Keck School of Medicine of USC (United States) |
| 16 | Piddock, Laura | University of Birmingham; Global Antibiotic Research and Development Partnership (United Kingdom) |
| 17 | Das, Shampa | University of Liverpool (United Kingdom) |
| 18 | Hope, William | University of Liverpool (United Kingdom) |